Whistler Medical Marijuana Corporation (WMMC), a Certified Organic Licensed Producer of Medical Cannabis, Today Announced the Release of Canada’s First High Cannabigerol (CBG) Cannabis Oil
WHISTLER, BC–(Marketwired – September 27, 2016) – The release follows two years of research identifying the best medical phenotypes from the diverse seed bank at WMMC. The process identified a unique phenotype containing significant amounts of both THC and CBG at maturity which now forms the starting material for their High CBG oil.
Cannabigerol (CBG) is a non-psychoactive cannabinoid which is currently being investigated for a multitude of medical properties. Whilst not as well studied as THC or CBD, initial research suggests it may have a wide range of medical benefits. Director of medical research at WMMC, Brishna Kamal, comments “Basic research has indicated that CBG exerts a variety of effects in cell culture and animal models including acting